PRESS RELEASES

Date	Title
Mar 8, 2021	Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
Feb 17, 2021	Ardelyx to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Nov 23, 2020	Ardelyx to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 10, 2020	Ardelyx to Present at the Jefferies Virtual London Healthcare Conference
Nov 6, 2020	Ardelyx to Webcast Virtual Analyst Day
Nov 5, 2020	Ardelyx Reports Third Quarter 2020 Financial Results and Business Highlights
Oct 22, 2020	Ardelyx and Kyowa Kirin Highlight New Data Supporting the Clinical Safety and Efficacy of First-In-Class, Phosphate Absorption Inhibitor Tenapanor at ASN's Kidney Week 2020
Oct 22, 2020	Ardelyx Launches 'Can We Do Better?' Campaign at ASN's Kidney Week 2020
Oct 12, 2020	Ardelyx Announces Data Supporting Efficacy and Safety of Tenapanor, a First-in-Class Phosphate Absorption Inhibitor, to be Presented at ASN's Kidney Week 2020
Sep 15, 2020	Ardelyx Announces FDA Acceptance for Filing of its New Drug Application of Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis

FAQs

Email Alerts

Connect

Bay Area
34175 Ardenwood Boulevard
Fremont, CA 94555

Greater Boston
400 Fifth Avenue, Suite 210
Waltham, MA 02451

Phone: 510.745.1700

Inquiries:
General: info@ardelyx.com
Media: media@ardelyx.com
Investor: investor@ardelyx.com
Business Development: partnering@ardelyx.com